The past year has marked a turning point for cell and gene therapies (CGTs), with the Food and Drug Administration (FDA) approving seven new therapies in 2023, bringing the total number of available treatments to 34. While the industry is
… ...
The post Game on: The high stakes and growing pains of bringing cell and gene therapies to market appeared first on Two Labs Pharma Services.